[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

KR830005217A - 이미다조 피리딘의 제조방법 - Google Patents

이미다조 피리딘의 제조방법 Download PDF

Info

Publication number
KR830005217A
KR830005217A KR1019810001015A KR810001015A KR830005217A KR 830005217 A KR830005217 A KR 830005217A KR 1019810001015 A KR1019810001015 A KR 1019810001015A KR 810001015 A KR810001015 A KR 810001015A KR 830005217 A KR830005217 A KR 830005217A
Authority
KR
South Korea
Prior art keywords
hydrogen
alkyl
imidazo pyridine
preparing imidazo
pyridinyl
Prior art date
Application number
KR1019810001015A
Other languages
English (en)
Inventor
요어 레셔어 죠오지
죠오지프 오팔카 쥬니어 체스터
프레드릭 페이지 도늘드
Original Assignee
원본미기재
스터어링 드럭그 인코포레이팃드
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 원본미기재, 스터어링 드럭그 인코포레이팃드 filed Critical 원본미기재
Publication of KR830005217A publication Critical patent/KR830005217A/ko

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/72—Nitrogen atoms
    • C07D213/76—Nitrogen atoms to which a second hetero atom is attached
    • C07D213/77—Hydrazine radicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/44—Radicals substituted by doubly-bound oxygen, sulfur, or nitrogen atoms, or by two such atoms singly-bound to the same carbon atom
    • C07D213/46—Oxygen atoms
    • C07D213/50—Ketonic radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/61—Halogen atoms or nitro radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Cardiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hospice & Palliative Care (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

내용 없음

Description

이미다조 피리딘의 제조방법
본 내용은 요부공개 건이므로 전문내용을 수록하지 않았음

Claims (1)

  1. 구조식 Ⅰ화합물(R1이 수소일때) 또는 구조식 IA화합물(R3가 수소일때)을 제조하기 위해서 R1또는 R3가 수소인 2-R3NH-3-R1NH-5-PY-6-Q-피리딘을 트리-(저급 알킬)오르토(저급-알카노에이트)와 반응시키고, 필요하다면, 얻어진 유리염기를 그의 산부가염으로 전환시킴을 특징으로 하는 하기 구조식Ⅰ 또는 IA를 갖는 이미다조 피리딘의 제조방법.
    상기식에서, Q와 R2는 각각 수소 또는 저급-알킬이며, R1과 R3는 수소, 저급-알킬, 저급-히드록시 알킬, 2,3-디하이드록시프로필, 저급-알콕시알킬 또는 Y-NB(여기서 Y는 연결고리이 적어도 2개의 탄소원자를 갖는 저급-알킬렌이며 NB는 디-(저급알킬)아미노 또는 4-모르폴리닐 임)이며 PY는 한두개의 저급-알킬 치환체를 갖는 4-혹은 3-피리디닐 또는 4-혹은 3-피리디닐 또는 그의 산부가염이다
    ※ 참고사항 : 최초출원 내용에 의하여 공개하는 것임.
KR1019810001015A 1980-03-28 1981-03-27 이미다조 피리딘의 제조방법 KR830005217A (ko)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US06/135,211 US4276293A (en) 1980-03-28 1980-03-28 Compositions and their preparation
US135211 1980-03-28

Publications (1)

Publication Number Publication Date
KR830005217A true KR830005217A (ko) 1983-08-03

Family

ID=22467044

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1019810001015A KR830005217A (ko) 1980-03-28 1981-03-27 이미다조 피리딘의 제조방법

Country Status (22)

Country Link
US (1) US4276293A (ko)
JP (1) JPS56150090A (ko)
KR (1) KR830005217A (ko)
AU (1) AU6883781A (ko)
BE (1) BE888088A (ko)
CA (1) CA1159061A (ko)
DE (1) DE3112197A1 (ko)
DK (1) DK136881A (ko)
ES (1) ES500727A0 (ko)
FI (1) FI810921L (ko)
FR (1) FR2479225A1 (ko)
GB (1) GB2072673B (ko)
IL (1) IL62403A0 (ko)
IT (1) IT1136972B (ko)
LU (1) LU83259A1 (ko)
NL (1) NL8101455A (ko)
NO (1) NO811041L (ko)
NZ (1) NZ196573A (ko)
PH (1) PH16999A (ko)
PT (1) PT72744B (ko)
SE (1) SE8101951L (ko)
ZA (1) ZA811776B (ko)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4363911A (en) * 1981-09-03 1982-12-14 Sterling Drug Inc. 1,2-Dihydro-6-[2-(dimethylamino)ethenyl]-2-oxo-5-(pyridinyl) nicotinonitriles
US4465686A (en) * 1981-09-08 1984-08-14 Sterling Drug Inc. 5-(Hydroxy- and/or amino-phenyl)-6-(lower-alkyl)-2-(1H)-pyridinones, their cardiotonic use and preparation
US4347363A (en) * 1981-09-17 1982-08-31 Sterling Drug Inc. Process for preparing 1,2-dihydro-6-methyl-2-oxo-5-(pyridinyl)nicotinonitriles
US4599423A (en) * 1982-04-26 1986-07-08 Sterling Drug Inc. Preparation of 5-(hydroxy- and/or aminophenyl-6-lower-alkyl)-2(1H)-pyridinones
US4413127A (en) * 1982-05-24 1983-11-01 Sterling Drug Inc. Preparation of 1,2-dihydro-6-(lower alkyl)-2-oxo-5-(pyridinyl)nicotinonitriles
US4469871A (en) * 1982-05-24 1984-09-04 Sterling Drug Inc. Process for preparing 2-(lower-alkoxy)-1-(pyridinyl) ethenyl lower-alkyl ketones
US4417054A (en) * 1982-05-24 1983-11-22 Sterling Drug Inc. 2-(Lower-alkoxy)-1-(pyridinyl)ethenyl lower-alkyl ketones
NZ204175A (en) * 1982-05-24 1985-12-13 Sterling Drug Inc Preparation of 1,2-dihydro-6-(lower alkyl)-2-oxo-5-(pyridinyl)-nicotinonitriles and nicotinamides;and pyridine intermediates therefor
US4595762A (en) * 1982-08-25 1986-06-17 Sterling Drug Inc. 5-α-bromoalkanoyl-2-oxo-3-pyridinecarbonitriles
US4539327A (en) * 1982-08-25 1985-09-03 Sterling Drug Inc. 5-(2-Substituted-4-thiazolyl)-6-alkyl-2(1H)-pyridinones and cardiotonic use thereof
US4469699A (en) * 1982-08-25 1984-09-04 Sterling Drug Inc. 5-(4-Thiazolyl)-6-alkyl-2(1H)-pyridinones and their cardiotonic use
US4448780A (en) * 1982-09-03 1984-05-15 Sterling Drug Inc. N-(Lower-alkyl)-N'-[5-(pyridinyl)-2-pyridinyl]ureas and cardiotonic use thereof
US4517192A (en) * 1983-01-31 1985-05-14 Sterling Drug Inc. 6-Alkyl-5-[4-(alkylsulfinyl or alkylsulfonyl)phenyl]-2(1H)-pyridinones and their use as cardiatonics
US4977144A (en) * 1988-08-02 1990-12-11 Ciba-Geigy Corporation Imidazo[4,5-b]pyridine derivatives as cardiovascular agents
AU3820989A (en) * 1988-08-02 1990-02-08 Ciba-Geigy Ag 7-amino-3-beta-d-ribofuranosyl-3h-imidazo(4,5-b) pyridin-5-amine derivatives
US5010086A (en) * 1990-02-28 1991-04-23 Sterling Drug Inc. Imidazopyridines, compositions and use
US4963561A (en) * 1990-02-28 1990-10-16 Sterling Drug Inc. Imidazopyridines, their preparation and use
US6465484B1 (en) * 1997-09-26 2002-10-15 Merck & Co., Inc. Angiogenesis inhibitors
ATE381595T1 (de) 2002-02-14 2008-01-15 Fujifilm Corp Verfahren zur optischen bestimmung von mehrsträngigen nucleinsäuren mit hilfe von cyaninfarbstoffen

Also Published As

Publication number Publication date
IT1136972B (it) 1986-09-03
GB2072673B (en) 1983-11-02
BE888088A (fr) 1981-09-24
IT8120784A0 (it) 1981-03-27
DE3112197A1 (de) 1982-02-25
US4276293A (en) 1981-06-30
NL8101455A (nl) 1981-10-16
PT72744A (en) 1981-04-01
AU6883781A (en) 1981-10-08
SE8101951L (sv) 1981-09-29
ZA811776B (en) 1982-04-28
NO811041L (no) 1981-09-28
ES8202343A1 (es) 1982-01-16
LU83259A1 (fr) 1981-10-29
JPS56150090A (en) 1981-11-20
FR2479225A1 (fr) 1981-10-02
FR2479225B1 (ko) 1984-05-18
NZ196573A (en) 1984-03-16
ES500727A0 (es) 1982-01-16
DK136881A (da) 1981-09-29
FI810921L (fi) 1981-09-29
IL62403A0 (en) 1981-05-20
CA1159061A (en) 1983-12-20
PH16999A (en) 1984-05-04
GB2072673A (en) 1981-10-07
PT72744B (en) 1982-03-24

Similar Documents

Publication Publication Date Title
KR830005217A (ko) 이미다조 피리딘의 제조방법
KR830005216A (ko) 이미다조[4,5-b] 피리딘 유도체의 제조방법
KR850006404A (ko) 니트로 메틸렌 유도체의 제조방법
KR850004111A (ko) 페노바비탈 및 카밤아제핀 공액체의 제조방법
KR860004049A (ko) 퀴놀론카복실산 유도체의 제조방법
KR840000533A (ko) 화합물의 제조방법
KR840005129A (ko) 2-(3-피리딜)-1,3,4-옥사디아졸류의 제조방법
KR850001149A (ko) 2-3차-부틸아미노-3'-클로로프로피오페논 말레에이트의 제조방법
KR830004292A (ko) 벤조구아나민 유도체의 제조방법
KR830005214A (ko) 1-R-5-PY-6-Q-1H-피라졸로[3,4-b] 피리딘-3-아민 또는 그의 산부가염의 제조방법
KR830005325A (ko) 수용성 화학 발광 시스템
KR830005191A (ko) 푸란유도체의 제조방법
KR860001105A (ko) 2-벤질-4-(4-피리딜)티아졸의 제조방법
JPS5344580A (en) 1,6-dihydropyridazine derivatives
KR840006238A (ko) 신규 α-아릴-α-피리딜알카노인산 유도체의 제조방법
KR850006180A (ko) 디아미노피리딘의 제조방법
JPS5344579A (en) Novel pyridazinium salt
KR850003407A (ko) 유기인산 에스테르 유도체의 제조방법
KR830005188A (ko) 혈당강하성 구아닐 아미딘의 제조방법
KR840004720A (ko) 살충제 조성물 및 이의 제조방법
KR830009044A (ko) 3,5-디-3급부틸-4-하이드록시페닐-치환 복소환 화합물의 제조방법
KR840001144A (ko) 5(6)-페닐설포닐옥시-벤즈이미다졸 유도체의 제조방법
KR840003639A (ko) 이속사졸로피리미딘 유도체의 제조방법
KR860000263A (ko) N-페닐(피리딜)술포닐디아미드의 제조방법
KR830010076A (ko) 옥타하이드로 피라졸로(3,4-g)퀴놀린

Legal Events

Date Code Title Description
PA0109 Patent application

Patent event code: PA01091R01D

Comment text: Patent Application

Patent event date: 19810327

PG1501 Laying open of application
PE0902 Notice of grounds for rejection

Comment text: Notification of reason for refusal

Patent event date: 19840426

Patent event code: PE09021S01D

PE0601 Decision on rejection of patent

Patent event date: 19840806

Comment text: Decision to Refuse Application

Patent event code: PE06012S01D

Patent event date: 19840426

Comment text: Notification of reason for refusal

Patent event code: PE06011S01I